ONC 8-K: SEC filing
BeOne Medicines Ltd.
Filed with the SEC on · accession 0001628280-26-070469
ONC filed a 8-K (current report) with the SEC on Nov 5, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +2.5% by the first close after the filing.
Summary of the filing
BeOne Medicines Ltd. announced its financial results for the three months ended September 30, 2026, via a press release furnished under Item 2.02 of Form 8-K.
Key details
How ONC stock reacted
Close before
$377.78
Nov 4, 2026
First close after
+2.51%
$387.25
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ONC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ONC?
Click hereFrequently asked questions
What did ONC file with the SEC on Nov 5, 2026?
ONC filed a 8-K (SEC filing). BeOne Medicines Ltd. announced its financial results for the three months ended September 30, 2026, via a press release furnished under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did ONC stock react to this filing?
ONC closed at $377.78 before the filing and $387.25 on Nov 5, 2026 (+2.51%).
Other ONC SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingAug 26, 2026
- 10-Q · SEC filingAug 5, 2026
- 8-K · SEC filingAug 5, 2026
- 144 · Insider sale plannedJul 10, 2026
- 144 · Insider sale plannedJul 10, 2026
- 8-K · Regulatory actionJun 26, 2026
- 8-K · SEC filingJun 11, 2026
- 8-K · Fda approvalMay 15, 2026
- 10-Q · SEC filingMay 6, 2026
Get alerts when ONC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days